Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
New to Comunitee?

or Sign Up with Email



NOV 01, 2013 - Time

A Must Read - Share

The HPV Vaccine and the Case for Race-Based Medicine

The human papillomavirus (HPV) vaccine, approved in 2006, protects against strains of the virus responsible for 70% of cervical cancers. But what about the remaining 30%? It turns out that those strains circulate more frequently among African-American and non-white Hispanic women, meaning that even if they are properly immunized, these populations aren’t protected against the sexually transmitted virus and the cancer it can cause. Researchers led by Dr. Cathrine Hoyo, Associate Professor of Obstetrics and Gynecology at Duke University Medical School, believe that could explain why ... Read More

Tags: The HPV Vaccine and the Case for Race-Based Medicine,  Cervical Cancer Latest News